These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
277 related articles for article (PubMed ID: 28574840)
41. Overexpression of FoxO3a is associated with glioblastoma progression and predicts poor patient prognosis. Qian Z; Ren L; Wu D; Yang X; Zhou Z; Nie Q; Jiang G; Xue S; Weng W; Qiu Y; Lin Y Int J Cancer; 2017 Jun; 140(12):2792-2804. PubMed ID: 28295288 [TBL] [Abstract][Full Text] [Related]
42. Epithelial membrane protein 3 regulates TGF-β signaling activation in CD44-high glioblastoma. Jun F; Hong J; Liu Q; Guo Y; Liao Y; Huang J; Wen S; Shen L Oncotarget; 2017 Feb; 8(9):14343-14358. PubMed ID: 27527869 [TBL] [Abstract][Full Text] [Related]
43. HEY1 functions are regulated by its phosphorylation at Ser-68. López-Mateo I; Arruabarrena-Aristorena A; Artaza-Irigaray C; López JA; Calvo E; Belandia B Biosci Rep; 2016 Jul; 36(3):. PubMed ID: 27129302 [TBL] [Abstract][Full Text] [Related]
44. FOXC2 often overexpressed in glioblastoma enhances proliferation and invasion in glioblastoma cells. Li W; Fu X; Liu R; Wu C; Bai J; Xu Y; Zhao Y; Xu Y Oncol Res; 2013; 21(2):111-20. PubMed ID: 24406047 [TBL] [Abstract][Full Text] [Related]
45. Epigenetic regulation of the secreted frizzled-related protein family in human glioblastoma multiforme. Schiefer L; Visweswaran M; Perumal V; Arfuso F; Groth D; Newsholme P; Warrier S; Dharmarajan A Cancer Gene Ther; 2014 Jul; 21(7):297-303. PubMed ID: 24948145 [TBL] [Abstract][Full Text] [Related]
46. Hypoxia enhances migration and invasion in glioblastoma by promoting a mesenchymal shift mediated by the HIF1α-ZEB1 axis. Joseph JV; Conroy S; Pavlov K; Sontakke P; Tomar T; Eggens-Meijer E; Balasubramaniyan V; Wagemakers M; den Dunnen WF; Kruyt FA Cancer Lett; 2015 Apr; 359(1):107-16. PubMed ID: 25592037 [TBL] [Abstract][Full Text] [Related]
47. Transcription factor 3 controls cell proliferation and migration in glioblastoma multiforme cell lines. Li R; Li Y; Hu X; Lian H; Wang L; Fu H Biochem Cell Biol; 2016 Jun; 94(3):247-55. PubMed ID: 27105323 [TBL] [Abstract][Full Text] [Related]
53. MicroRNA-101 reverses temozolomide resistance by inhibition of GSK3β in glioblastoma. Tian T; Mingyi M; Qiu X; Qiu Y Oncotarget; 2016 Nov; 7(48):79584-79595. PubMed ID: 27792996 [TBL] [Abstract][Full Text] [Related]
54. MiR-153 as a Tumor Suppressor in Glioblastoma Multiforme is Downregulated by DNA Methylation. Ghasemi A; Fallah S; Ansari M Clin Lab; 2016; 62(4):573-80. PubMed ID: 27215075 [TBL] [Abstract][Full Text] [Related]
55. The Fukusumi T; Guo TW; Sakai A; Ando M; Ren S; Haft S; Liu C; Amornphimoltham P; Gutkind JS; Califano JA Clin Cancer Res; 2018 Feb; 24(3):619-633. PubMed ID: 29146722 [No Abstract] [Full Text] [Related]
56. A five-miRNA signature with prognostic and predictive value for MGMT promoter-methylated glioblastoma patients. Cheng W; Ren X; Cai J; Zhang C; Li M; Wang K; Liu Y; Han S; Wu A Oncotarget; 2015 Oct; 6(30):29285-95. PubMed ID: 26320189 [TBL] [Abstract][Full Text] [Related]
57. Methylation and silencing of the Thrombospondin-1 promoter in human cancer. Li Q; Ahuja N; Burger PC; Issa JP Oncogene; 1999 May; 18(21):3284-9. PubMed ID: 10359534 [TBL] [Abstract][Full Text] [Related]